Turning Point Therapeutics
(NASDAQ) TPTX
This security has been delisted. This page is retained for historical reference.
TPTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowTPTX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-8%
Net Income Margin
-8%
Return on Equity
-23%
Return on Capital
-25%
Return on Assets
-24%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$30.83M
Operating Income
$236.55M
EBITDA
$232.58M
Operating Cash Flow
$153.88M
Capital Expenditure
$2.43M
Free Cash Flow
$156.31M
Cash & ST Invst.
$981.58M
Total Debt
$5.58M
Turning Point Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonCurrently no data to display.
Quarterly Performance
Revenue
$119.00K
-97.7%
Gross Profit
$119.00K
-97.7%
Gross Margin
100.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
267
N/A
Net Income
$123.09M
-118.7%
EBITDA
$121.77M
-118.2%
Quarterly Fundamentals
Net Cash
$813.35M
-24.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$890.00K
-74.7%
Short Term Debt
$4.05M
+35.6%
Return on Assets
-23.57%
N/A
Return on Invested Capital
-24.73%
N/A
Free Cash Flow
$106.83M
-147.8%
Operating Cash Flow
$105.30M
-148.4%